跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ibanox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ibanox
Approved
STANDARD
Ibanox
Pharmathen SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dde9a0992efba291
Company
Pharmathen SA
Type
Standard
Approval Details
Approval Id
dde9a0992efba291
Drug Approval Philippines Name
Ibanox
Product Name
Ibanox
Registration Number
DRP-11586
Brand Name
Ibanox
Generic Name
Ibandronic Acid (as sodium monohydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Pharmathen SA
Importer
Sandoz Philippines Corporation
Company Detail Path
/organization/pharmathen-sa
Issuance Date
30 March 2022
Expiry Date
30 March 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dde9a0992efba291
Type
Standard
Back to Philippines FDA Approvals